TopFunds

Biogen

NASDAQ: BIIB

Stock price

215.5 USD

(-28.21%) 5 years

BiotechnologyDrug Manufacturers - General

Insider Transactions

5Y price score: (38)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -28.21%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
01-sep.-26Award7,405--7,405Parini Michaelofficer: Chief Legal Officerlink
04-aug.-26Sale(593)201.0(119,169)2,689Minor Lloyddirectorlink
03-aug.-26Sale(593)203.3(120,581)3,282Minor Lloyddirectorlink
09-jun.-26Award1,505--10,365HAWKINS WILLIAM Adirectorlink
09-jun.-26Award1,505--15,193SHERWIN STEPHEN Adirectorlink
09-jun.-26Award1,505--25,844Rowinsky Eric Kdirectorlink
09-jun.-26Award1,505--11,263Mantas Jesus Bdirectorlink
09-jun.-26Award1,505--6,634LANGER SUSANdirectorlink
09-jun.-26Award1,505--5,215Patolawala Monish Ddirectorlink
09-jun.-26Award1,505--3,875Pangalos Menelas Ndirectorlink

135.3

52-week range

225.8

215.5

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

9.3 %

Dividend Yield TTM

-

Market cap $

$ 31,841

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

38.1

Price / Book TTM

1.7

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

(1.8)

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

49.9 %

(28.2) %

(29.2) %

Free cash flow per share growth

233 %

(40.7) %

5.2 %

Earnings per share growth

(84.8) %

(64.4) %

(42.4) %

Analyst ratings

Price Target Low

175

Price Target High

300

Price Target Median

246.5

Buy

31

Hold

17

Sell

1

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
15.3
16.9
11.9
21.6
31.4
24.8
10.4
20.9
8
11.2
8.8
(5.4)%
17.4
18
18.7
19.4
20.1
21.6
02FCF per share
13.3
17.9
17.3
26.4
35
23.6
22.6
7.8
8.5
17.2
14
0.5%
21.3
22.2
23.1
24.1
25
27.1
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
05Revenue
$ 10,764
$ 11,449
$ 12,274
$ 13,453
$ 14,378
$ 13,445
$ 10,982
$ 10,173
$ 9,836
$ 9,676
$ 9,811
(0.9)%
$ 9,720
$ 9,630
$ 9,542
$ 9,453
$ 9,366
$ 9,647
06ㅤ% Change
-
6.4%
7.2%
9.6%
6.9%
(6.5)%
(18.3)%
(7.4)%
(3.3)%
(1.6)%
1.4%
(0.9)%
(0.9)%
(0.9)%
(0.9)%
(0.9)%
(0.9)%
(0.9)%
07Net Income
3,547
3,703
2,539
4,431
5,889
4,001
1,556
3,047
1,161
1,632
1,293
(9.6)%
2,435
2,413
2,391
2,369
2,347
2,417
08ㅤ% Margin
33%
32.3%
20.7%
32.9%
41%
29.8%
14.2%
30%
11.8%
16.9%
13.2%
25.1% A
25.1%
25.1%
25.1%
25.1%
25.1%
25.1%
09CFO
3,716
4,522
4,551
6,188
7,079
4,230
3,640
1,384
1,547
2,876
2,205
(5.1)%
3,115
3,086
3,057
3,029
3,001
3,091
10ㅤ% Of revenue
34.5%
39.5%
37.1%
46%
49.2%
31.5%
33.2%
13.6%
15.7%
29.7%
22.5%
32% A
32%
32%
32%
32%
32%
32%
11CAPEX
(643)
(616.1)
(867.4)
(770.6)
(514.5)
(424.8)
(258.1)
(240.3)
(311.4)
(359.8)
(153.8)
(13.3)%
(133.3)
(115.5)
(100.1)
(86.8)
(75.2)
(65.2)
12ㅤ% Change
-
(4.2)%
40.8%
(11.2)%
(33.2)%
(17.4)%
(39.2)%
(6.9)%
29.6%
15.5%
(57.3)%
(13.3)% A
(13.3)%
(13.3)%
(13.3)%
(13.3)%
(13.3)%
(13.3)%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
3,073
3,906
3,684
5,417
6,564
3,805
3,382
1,144
1,236
2,516
2,051
(4)%
2,981
2,970
2,957
2,942
2,926
3,026
14Total assets
19,505
22,877
23,653
25,289
27,234
24,619
23,877
24,554
26,845
28,049
29,440
4.2%
30,677
31,966
33,309
34,709
36,168
37,688
15ㅤ% Change
-
17.3%
3.4%
6.9%
7.7%
(9.6)%
(3)%
2.8%
9.3%
4.5%
5%
4.2%
4.2%
4.2%
4.2%
4.2%
4.2%
4.2%
16Total liabilities
10,130
10,748
11,055
12,257
13,895
13,933
12,918
11,166
12,045
11,333
11,183
1%
11,653
12,142
12,653
13,185
13,739
14,316
17ㅤ% Of assets
51.9%
47%
46.7%
48.5%
51%
56.6%
54.1%
45.5%
44.9%
40.4%
38%
38% A
38%
38%
38%
38%
38%
38%
18Shareholders Equity
9,375
12,129
12,598
13,032
13,339
10,686
10,960
13,388
14,799
16,716
18,257
6.9%
19,024
19,824
20,657
21,525
22,430
23,372
19Net Debt
5,218
4,191
4,364
4,712
3,454
6,497
5,342
3,195
6,288
4,255
3,940
(2.8)%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
231,200
218,800
213,000
205,300
187,400
161,300
149,600
146,000
145,600
145,900
146,700
(4.5)%
140,176
133,943
127,986
122,295
116,856
111,659
21ㅤ% Change
-
(5.4)%
(2.7)%
(3.6)%
(8.7)%
(13.9)%
(7.3)%
(2.4)%
(0.3)%
0.2%
0.6%
(4.5)%
(4.5)%
(4.5)%
(4.5)%
(4.5)%
(4.5)%
(4.5)%
22ROA
18.2%
16.2%
10.7%
17.5%
21.6%
16.3%
6.5%
12.4%
4.3%
5.8%
4.4%
-
7.9%
7.6%
7.2%
6.8%
6.5%
6.4%
23ROE
37.8%
30.5%
20.2%
34%
44.1%
37.4%
14.2%
22.8%
7.9%
9.8%
7.1%
-
12.8%
12.2%
11.6%
11%
10.5%
10.3%
24Interest coverage
51.2
19.8
21.3
29.4
37.6
20.6
11
11.7
8.5
9.9
7.6
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
26P/E Ratio
19.9
16.7
26.7
13.9
9.4
9.8
23
13.2
32.3
13.7
19.9
-
-
-
-
-
-
-
27Stock price range
256-476
225-330
247-345
258-384
217-339
236-356
224-415
188-307
223-318
146-268
113-182
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
70,675
61,934
67,728
61,659
55,518
39,398
35,772
40,237
37,444
22,280
25,818
(9.6)%
34,115
37,920
42,106
46,711
51,776
-
29FCF Yield
4.4%
6.2%
5.4%
8.6%
11.8%
9.7%
9.5%
2.8%
3.3%
11.3%
7.9%
6.2%
8.7%
7.8%
7%
6.3%
5.7%
-
30Average stock price
366
277.4
295.6
320.7
277.8
295.9
319.3
247.1
270.3
207.1
147.7
(8.7)%
243.4
283.1
329
382
443.1
-
31 CEO
CV
Christopher A. Viehbacher